tiletamine hydrochloride has been researched along with Disease Models, Animal in 61 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (8.20) | 18.2507 |
2000's | 11 (18.03) | 29.6817 |
2010's | 37 (60.66) | 24.3611 |
2020's | 8 (13.11) | 2.80 |
Authors | Studies |
---|---|
Chattipakorn, N; Chen, X; Feng, J; Guan, X; Jin, L; Liang, G; Luo, W; Pavlov, VN; Samorodov, AV; Wang, M; Wang, Y; Yang, D; Ye, L; Zhuang, Z | 1 |
El-Salhy, M; Keino, H; Kubota, T; Ma, J; Ozaki, M; Sugai, T; Umezawa, K; Zhang, Y | 1 |
Chen, W; Cheng, F; Rao, T; Ruan, Y; Song, H; Xia, Y; Yu, W; Zhao, S; Zhu, S | 1 |
Abe, Y; Fujisaki, H; Hasegawa, Y; Hori, S; Ishihara, K; Itano, O; Kishino, S; Kitagawa, Y; Kitago, M; Konno, T; Matsuda, S; Nakano, Y; Ohno, K; Suzuki, K; Tanaka, M; Umezawa, K; Yagi, H | 1 |
Davison, AS; Gallagher, JA; Hughes, AT; Milan, AM; Ranganath, LR; Sireau, N | 1 |
Abrar Shahriyar, S; Alam, MB; Kwon, YG; Lee, SH; Simu, SY | 1 |
Branson, S; Casimir, G; Claes, P; Colemonts-Vroninks, H; De Kock, J; Goyens, P; Marcelis, L; Martens, GA; Neuckermans, J; Vanhaecke, T | 1 |
Bordignon, A; Cieckiewicz, E; Di Giovanni, N; Frédérich, M; Hoareau, F; Illien, B; Jansen, O; Ledoux, A; Marvilliers, A; Pendeville, H; Quetin-Leclercq, J; St-Gelais, A | 1 |
Cech, NB; Crosby, HA; Heilmann, KP; Horswill, AR; Malone, CL; Parlet, CP; Todd, DA | 1 |
Bauer-Erickson, J; Berquist, MD; Fantegrossi, WE; Gannon, BM; Hyatt, WS; Norwood, AP | 1 |
Du, F; Fan, S; Guo, W; Homanics, GE; Hou, Y; Liu, D; Lu, J; Pan, T; Xiong, W; Yao, L; Zhang, L; Zou, G | 1 |
Cruz, LIB; de Oliveira, RB; de Paula, LFJ; de Sá, NP; de Souza-Fagundes, EM; Fuchs, BB; Johann, S; Lino, CI; Lopes, LFF; Matos, TTS; Mylonakis, E | 1 |
Fukatsu, H; Ichihara, S; Ikegami, A; Izuoka, K; Koide, N; Komatsu, T; Morita, N; Naiki, Y; Tada-Oikawa, S; Ukaji, T; Umezawa, K | 1 |
Abu-Asab, MS; Adams, DR; Aderemi, JO; Albert, JS; Alur, RP; Bernardini, IM; Brooks, BP; Chan, CC; Cogliati, T; Megan, LH; Melch, MG; Onojafe, IF | 1 |
Adam, D | 1 |
Gao, X; He, H; Jiang, X; Li, X; Ma, J; Ma, K; Umezawa, K; Wang, X; Xie, Z; Zhang, Y | 1 |
Ando, Y; Hirakata, A; Keino, H; Kudo, A; Okada, AA; Umezawa, K | 1 |
Gallagher, JA; Jarvis, JC; Keenan, CM; Preston, AJ; Ranganath, LR; Sutherland, H; Taylor, AM; Williams, DP; Wilson, PJ; Wlodarski, B | 1 |
Akhtar, MN; Akira, A; Ali, DI; Khalivulla, SI; Lajis, N; Ming-Tatt, L; Perimal, EK; Sulaiman, MR | 1 |
Qi, Z; Sun, R; Tian, Z; Wang, X; Wei, H | 1 |
Jiang, W; Ma, H; Ma, L; Meng, XD; Wang, L; Wu, C; Yang, F | 1 |
Baba, M; Fujiyoshi, M; Haga, S; Kamiyama, T; Mino, K; Nakanishi, K; Niwa, H; Ohmiya, Y; Ozaki, M; Sato, M; Taketomi, A; Todo, S; Umezawa, K; Yokoo, H | 1 |
Gallagher, JA; Ranganath, LR; Timmis, OG | 1 |
Gao, X; Li, L; Qi, Z; Sun, R; Tian, Z; Wang, X; Wei, H; Zeng, Z | 1 |
Bezerra, DP; Bomfim, LM; Campos, AF; Costa, EV; Dias, RB; Menezes, LR; Nascimento, MP; Neto, AF; Rocha, CA; Rodrigues, AC; Silva, LC; Soares, MB | 1 |
El-Salhy, M; Umezawa, K | 2 |
Barnby, E; Coker, SB; Hillgartner, MA; Koenig, AE; MacGregor, GG; Moore, ME | 1 |
Amiot, B; Chen, H; DeGrado, TR; Elgilani, F; Freeman, BL; Glorioso, J; Grompe, M; Harding, CO; Hickey, RD; Ho, CS; Ibrahim, SH; Ikeda, Y; Jiang, H; Lillegard, JB; Mao, SA; Marler, R; Nyberg, SL; O'Connor, MK; Peng, KW; Rinaldo, P; Russell, SJ; Suksanpaisan, L | 1 |
Barzi, M; Bissig, KD; Bissig-Choisat, B; Borowiak, M; Elsea, SH; Hubert, L; Legras, X; Mi, T; Pankowicz, FP; Ravishankar, M; Sumazin, P; Sun, Q; Tomolonis, JA; Yang, D | 1 |
Fukushima, T; Kanemaru, A; Kataoka, H; Kawaguchi, M; Tanaka, H; Umezawa, K; Yamamoto, K | 1 |
Dong, C; Hashimoto, K; Honda, T; Ishima, T; Ma, M; Ren, Q; Saito, A; Yang, C; Yao, W; Zhang, JC | 1 |
Finegold, M; Grompe, M; Lee, AY; Rothfuss, A; Sharma, AD; Vogel, A; Wang, Z; Willenbring, H | 1 |
Aoyagi, T; Fukai, M; Furukawa, H; Jomen, W; Ozaki, M; Suzuki, T; Todo, S; Ueki, S; Umezawa, K; Yamashita, K | 1 |
Ishida, S; Iwabuchi, K; Iwata, D; Kitaichi, N; Miyazaki, A; Namba, K; Ohno, S; Onoé, K; Ozaki, M; Todo, S; Umezawa, K; Yamashita, K; Yoshida, K | 1 |
Horiguchi, Y; Kanai, K; Kikuchi, E; Kodaira, K; Kosugi, M; Matsumoto, K; Miyajima, A; Nakagawa, K; Oya, M; Suzuki, E; Tachibana, M; Umezawa, K | 1 |
Dahlke, MH; Doenecke, A; Eggenhofer, E; Geissler, EK; Piso, P; Popp, FC; Renner, P; Schlitt, HJ; Slowik, P | 1 |
Abe, R; Hamasaka, A; Kishino, S; Ozaki, M; Shimizu, H; Todo, S; Umezawa, K; Yoshioka, N | 1 |
Ishida, S; Kato, N; Kubota, M; Kubota, S; Kurihara, T; Miyashita, H; Noda, K; Ozawa, Y; Shimmura, S; Tsubota, K; Umezawa, K; Usui, T | 1 |
Berk, M; Bush, AI; Copolov, DL; Dean, OM; Mavros, C; van den Buuse, M | 1 |
Bleidissel, M; Cantz, T; Gentile, L; Greber, B; Han, DW; Liu, N; Ott, M; Rittelmeyer, I; Rudolph, C; Schambach, A; Schöler, HR; Sgodda, M; Sharma, AD; Steinemann, D; Wu, G; Zaehres, H | 1 |
Li, J; Li, X; Liang, G; Pan, Y; Wang, Y; Yang, S; Ye, F; Yu, C; Zhang, H; Zhang, Y | 1 |
Akhtar, MN; Akira, A; Israf, DA; Khalid, MH; Khalivulla, SI; Lajis, N; Ming-Tatt, L; Mohamad, AS; Perimal, EK; Sulaiman, MR | 1 |
Adams, DR; Alur, RP; Bernardini, IM; Brilliant, MH; Brooks, BP; Chan, CC; Dolinska, MB; Gahl, WA; Onojafe, IF; Sergeev, YV; Simeonov, DR; Zhang, J | 1 |
Arvanites, AC; Benmohamed, R; Ferrante, RJ; Kirsch, DR; Morimoto, RI; Silverman, RB; Zhang, W | 1 |
Konno, S; Nishimura, M; Ozaki, M; Shimizu, K; Todo, S; Umezawa, K; Yamashita, K | 1 |
Aiura, K; Itano, O; Kitagawa, Y; Matsuda, S; Suzuki, K; Takeuchi, O; Umezawa, K | 1 |
Bond, GR; Goetz, RJ; Lindsell, CJ; Otten, EJ; Sztajnkrycer, MD | 1 |
Berger, R; Grompe, M; Jacobs, SM; Klomp, LW; Luijerink, MC; Malingré, HE; van Beurden, EA; van den Berg, IE | 1 |
Dewan, MZ; Higashihara, M; Honda, M; Horie, R; Itoh, K; Mizoguchi, H; Okamura, T; Sasaki, M; Sata, T; Umezawa, K; Watanabe, M; Watanabe, T; Yamamoto, N | 1 |
Horie, R; Ishida, A; Ishida, T; Kumasaka, T; Ohsugi, T; Umezawa, K; Urano, T; Watanabe, T; Yamaguchi, K | 1 |
Horiguchi, Y; Kanao, K; Kikuchi, E; Kuroda, K; Miyajima, A; Murai, M; Nakashima, J; Ohigashi, T; Umezawa, K | 1 |
Kubota, T; Miyasaka, N; Nanki, T; Umezawa, K; Wakamatsu, K | 1 |
Bergeron, A; Finegold, MJ; Jorquera, R; Langlois, C; Orejuela, D; Rhead, WJ; Tanguay, RM | 1 |
Bergeron, A; Finegold, MJ; Jorquera, R; Orejuela, D; Tanguay, RM | 1 |
al-Dhalimy, M; Finegold, M; Grompe, M; Kennaway, NG; Lindstedt, S; Ou, CN; Papaconstantinou, J; Torres-Ramos, CA | 1 |
Al-Dhalimy, M; Brantly, M; Finegold, M; Grompe, M; Ou, CN; Overturf, K; Tanguay, R | 1 |
Holme, E; Lindstedt, S | 1 |
Al-Dhalimy, M; Finegold, M; Grompe, M; Manning, K; Ou, CN; Overturf, K | 1 |
Maeda, Y; Oda, K; Suzuki, T; Suzuki, Y; Yoshikawa, Y | 1 |
Al-Dhalimy, M; Finegold, M; Grompe, M; Overturf, K | 1 |
3 review(s) available for tiletamine hydrochloride and Disease Models, Animal
Article | Year |
---|---|
Inhibition of Cellular and Animal Inflammatory Disease Models by NF-κB Inhibitor DHMEQ.
Topics: Animals; Anti-Inflammatory Agents; Benzamides; Cyclohexanones; Disease Models, Animal; Humans; Inflammation; Mice; NF-kappa B | 2021 |
Alkaptonuria - Many questions answered, further challenges beckon.
Topics: Alkaptonuria; Animals; Cyclohexanones; Disease Models, Animal; Enzyme Inhibitors; Homogentisic Acid; Humans; Mice; Nitrobenzoates; Tyrosine | 2020 |
Diagnosis and management of tyrosinemia type I.
Topics: 4-Hydroxyphenylpyruvate Dioxygenase; Amino Acid Metabolism, Inborn Errors; Animals; Cyclohexanones; Disease Models, Animal; Enzyme Inhibitors; Genetic Therapy; Humans; Liver Transplantation; Nitrobenzoates; Phenotype; Tyrosine | 1995 |
58 other study(ies) available for tiletamine hydrochloride and Disease Models, Animal
Article | Year |
---|---|
Curcumin analogue C66 attenuates obesity-induced myocardial injury by inhibiting JNK-mediated inflammation.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Benzylidene Compounds; Cardiomyopathies; Cell Line; Cyclohexanones; Cytokines; Diet, High-Fat; Disease Models, Animal; JNK Mitogen-Activated Protein Kinases; Male; Mice, Inbred C57BL; Myocarditis; Myocytes, Cardiac; NF-kappa B; Obesity; Palmitic Acid; Rats; Signal Transduction | 2021 |
SC66 inhibits the proliferation and induces apoptosis of human bladder cancer cells by targeting the AKT/β-catenin pathway.
Topics: Animals; Apoptosis; beta Catenin; Biomarkers; Cell Cycle; Cell Line, Tumor; Cells, Cultured; Cyclohexanones; Disease Models, Animal; Dose-Response Relationship, Drug; Epithelial-Mesenchymal Transition; Humans; Mice; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyridines; Signal Transduction; Urinary Bladder Neoplasms | 2021 |
Intravenous Administration of Dehydroxymethylepoxyquinomicin With Polymer Enhances the Inhibition of Pancreatic Carcinoma Growth in Mice.
Topics: Administration, Intravenous; Animals; Antineoplastic Agents; Apoptosis; Benzamides; Cell Cycle; Cell Line, Tumor; Cyclohexanones; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Carriers; Drug Delivery Systems; Humans; Mice; Molecular Structure; Polymers; Protein Kinase Inhibitors; Xenograft Model Antitumor Assays | 2021 |
Attenuation of Inflammatory Symptoms by Icariside B2 in Carrageenan and LPS-Induced Inflammation Models via Regulation of MAPK/NF-κB Signaling Cascades.
Topics: Animals; Anti-Inflammatory Agents; Carrageenan; Cyclohexanones; Disease Models, Animal; Edema; Epimedium; Gene Expression Regulation; Glucosides; Lipopolysaccharides; MAP Kinase Signaling System; Mice; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; NF-kappa B; Norisoprenoids; Phosphorylation; Plant Extracts | 2020 |
Oxidative Stress, Glutathione Metabolism, and Liver Regeneration Pathways Are Activated in Hereditary Tyrosinemia Type 1 Mice upon Short-Term Nitisinone Discontinuation.
Topics: Animals; Cyclohexanones; Disease Models, Animal; Glutathione; Humans; Hydrolases; Liver; Liver Regeneration; Medication Adherence; Mice; Mice, Knockout; NF-E2-Related Factor 2; Nitrobenzoates; Oxidative Stress; Oxidoreductases; Signal Transduction; Tyrosine; Tyrosinemias; Withholding Treatment | 2020 |
Antimalarial Activities of Alkyl Cyclohexenone Derivatives Isolated from the Leaves of Poupartia borbonica.
Topics: Anacardiaceae; Animals; Antimalarials; Belgium; Cyclohexanones; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Flavonoids; HeLa Cells; Humans; Inhibitory Concentration 50; Malaria; Mice; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Parasitic Sensitivity Tests; Plant Leaves; Plasmodium berghei; Plasmodium falciparum; Quercetin; Zebrafish | 2017 |
Signal Biosynthesis Inhibition with Ambuic Acid as a Strategy To Target Antibiotic-Resistant Infections.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Cyclohexanones; Disease Models, Animal; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Peptides, Cyclic; Quorum Sensing; Signal Transduction; Staphylococcal Infections; Virulence Factors | 2017 |
Phencyclidine-like in vivo effects of methoxetamine in mice and rats.
Topics: Animals; Body Temperature; Cyclohexanones; Cyclohexylamines; Discrimination, Psychological; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Illicit Drugs; Locomotion; Male; Mice; Phencyclidine; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Self Administration; Substance Withdrawal Syndrome; Telemetry | 2018 |
Involvement of glycine receptor α1 subunits in cannabinoid-induced analgesia.
Topics: Action Potentials; Analgesics; Animals; Animals, Genetically Modified; Cannabinoids; Cyclohexanones; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Freund's Adjuvant; Gene Expression Regulation; Glycine Agents; HEK293 Cells; Humans; In Vitro Techniques; Inflammation; Male; Mice; Mice, Inbred C57BL; Mutation; Neurons; Pain; Pain Measurement; Patch-Clamp Techniques; Receptors, Glycine; Reflex, Startle; Rotarod Performance Test; Spinal Cord; Strychnine; Time Factors; Transfection | 2018 |
In vivo and in vitro activity of a bis-arylidenecyclo-alkanone against fluconazole-susceptible and -resistant isolates of Candida albicans.
Topics: Animals; Antifungal Agents; Caenorhabditis elegans; Candida albicans; Candidiasis; Cyclohexanones; Disease Models, Animal; Drug Resistance, Fungal; Female; Fluconazole; Humans; Mice; Microbial Sensitivity Tests | 2018 |
NF‑κB inhibitor DHMEQ inhibits titanium dioxide nanoparticle‑induced interleukin‑1β production: Inhibition of the PM2.5‑induced inflammation model.
Topics: Animals; Benzamides; Biomarkers; Caspase 1; Caspase Inhibitors; Cell Line; Cyclohexanones; Disease Models, Animal; Humans; Inflammation; Interleukin-1beta; Macrophages; Models, Molecular; Nanoparticles; NF-kappa B; Particulate Matter; Potassium; Titanium | 2018 |
Minimal Efficacy of Nitisinone Treatment in a Novel Mouse Model of Oculocutaneous Albinism, Type 3.
Topics: Administration, Oral; Albinism, Oculocutaneous; Animals; Blotting, Western; Cyclohexanones; Disease Models, Animal; Enzyme Inhibitors; Genotyping Techniques; Melanins; Melanosomes; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Microscopy, Electron, Transmission; Nitrobenzoates; Oxidoreductases; Real-Time Polymerase Chain Reaction; Treatment Outcome; Tyrosine | 2018 |
A father's fight to help his sons - and fix clinical trials.
Topics: Adolescent; Alkaptonuria; Animals; Autopsy; Child; Clinical Trials as Topic; Compassionate Use Trials; Cyclohexanones; Disease Models, Animal; Disease Progression; Drug Approval; Endpoint Determination; Female; Homogentisic Acid; Humans; Infant; Male; Mice; National Health Programs; National Institutes of Health (U.S.); Nitrobenzoates; Observational Studies as Topic; Off-Label Use; Orphan Drug Production; Rare Diseases; Rats; Sample Size; Tyrosine; Tyrosinemias; United States; United States Food and Drug Administration | 2019 |
Comparison of anti-atopic dermatitis activities between DHMEQ and tacrolimus ointments in mouse model without stratum corneum.
Topics: Animals; Benzamides; Cyclohexanones; Cytokines; Dermatitis, Atopic; Dinitrochlorobenzene; Disease Models, Animal; Epidermis; Female; Humans; Immunoglobulin E; Immunosuppressive Agents; Inflammation Mediators; Mast Cells; Mice; Mice, Inbred BALB C; Ointments; Oxazolone; Tacrolimus | 2019 |
Anti-Inflammatory Effect of Dehydroxymethylepoxyquinomicin, a Nuclear factor-κB Inhibitor, on Endotoxin-Induced Uveitis in Rats In vivo and In vitro.
Topics: Animals; Aqueous Humor; Benzamides; Cells, Cultured; Cyclohexanones; Disease Models, Animal; Immunohistochemistry; Male; NF-kappa B; Rats, Inbred Lew; Treatment Outcome; Uveitis | 2020 |
Ochronotic osteoarthropathy in a mouse model of alkaptonuria, and its inhibition by nitisinone.
Topics: 4-Hydroxyphenylpyruvate Dioxygenase; Alkaptonuria; Animals; Chondrocytes; Cyclohexanones; Disease Models, Animal; Enzyme Inhibitors; Female; Humans; Joint Diseases; Knee Joint; Male; Mice; Mice, Inbred BALB C; Mice, Knockout; Nitrobenzoates; Ochronosis | 2014 |
Anti-hyperalgesic effect of a benzilidine-cyclohexanone analogue on a mouse model of chronic constriction injury-induced neuropathic pain: Participation of the κ-opioid receptor and KATP.
Topics: Animals; Benzylidene Compounds; Cyclohexanones; Disease Models, Animal; KATP Channels; Male; Mice; Mice, Inbred BALB C; Neuralgia; Receptors, Opioid, kappa; Signal Transduction | 2013 |
Infiltrating neutrophils aggravate metabolic liver failure in fah-deficient mice.
Topics: Animals; Bilirubin; Body Weight; Cyclohexanones; Disease Models, Animal; Hepatocytes; Hydrolases; Inflammation; Interleukin-22; Interleukins; Liver; Liver Failure; Male; Mice; Mice, Knockout; Neutrophils; Nitrobenzoates; Receptors, CCR2; Tyrosine | 2015 |
Disease-modifying effects of RHC80267 and JZL184 in a pilocarpine mouse model of temporal lobe epilepsy.
Topics: Animals; Anticonvulsants; Benzodioxoles; Cyclohexanones; Disease Models, Animal; Electroencephalography; Epilepsy, Temporal Lobe; Exploratory Behavior; Hindlimb Suspension; Hippocampus; Male; Maze Learning; Mice; Mice, Inbred C57BL; Neurodegenerative Diseases; Piperidines | 2014 |
Anoikis induction and inhibition of peritoneal metastasis of pancreatic cancer cells by a nuclear factor-κB inhibitor, (-)-DHMEQ.
Topics: Animals; Anoikis; Apoptosis Regulatory Proteins; Benzamides; Cell Line, Tumor; Cyclohexanones; Disease Models, Animal; Gene Expression; Genes, Reporter; Humans; Mice; Molecular Imaging; NF-kappa B; Pancreatic Neoplasms; Peritoneal Neoplasms; Protein Binding; Transcription Factor RelA; Tumor Burden; Xenograft Model Antitumor Assays | 2013 |
Progress in Alkaptonuria--are we near to an effective therapy?
Topics: Alkaptonuria; Animals; Cyclohexanones; Disease Models, Animal; Genetic Therapy; Humans; Mice; Nitrobenzoates; Ochronosis; Treatment Outcome | 2015 |
Natural Killer Cells-Produced IFN-γ Improves Bone Marrow-Derived Hepatocytes Regeneration in Murine Liver Failure Model.
Topics: Animals; Bone Marrow Cells; Bone Marrow Transplantation; Cell Fusion; Cyclohexanones; Disease Models, Animal; Female; Hepatocytes; Hydrolases; Interferon gamma Receptor; Interferon-gamma; Killer Cells, Natural; Liver Failure; Liver Regeneration; Male; Mice; Mice, Knockout; Monocytes; Nitrobenzoates; Protein Binding; Receptors, Interferon | 2015 |
Antitumour Activity of the Microencapsulation of Annona vepretorum Essential Oil.
Topics: Acyclic Monoterpenes; Adult; Alkenes; Animals; Annona; Antineoplastic Agents, Phytogenic; beta-Cyclodextrins; Bicyclic Monoterpenes; Cell Line, Tumor; Cyclohexane Monoterpenes; Cyclohexanones; Disease Models, Animal; Drug Compounding; Gas Chromatography-Mass Spectrometry; Hep G2 Cells; Humans; Inhibitory Concentration 50; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Monoterpenes; Oils, Volatile; Plant Leaves; Sesquiterpenes; Sesquiterpenes, Germacrane; Terpenes; Young Adult | 2016 |
Treatment with novel AP-1 and NF-κB inhibitors restores the colonic endocrine cells to normal levels in rats with DSS-induced colitis.
Topics: Animals; Anti-Inflammatory Agents; Benzamides; Carboxymethylcellulose Sodium; Colitis; Colon; Cyclohexanones; Dextran Sulfate; Disease Models, Animal; Endocrine Cells; Male; NF-kappa B; Piperidones; Rats; Rats, Wistar; Transcription Factor AP-1 | 2016 |
Tyrosinemia type I and not treatment with NTBC causes slower learning and altered behavior in mice.
Topics: Animals; Behavior, Animal; Cyclohexanones; Disease Models, Animal; Hydrolases; Learning; Memory, Long-Term; Mice; Nitrobenzoates; Tyrosine; Tyrosinemias | 2016 |
Effects of AP‑1 and NF‑κB inhibitors on colonic endocrine cells in rats with TNBS‑induced colitis.
Topics: Animals; Benzamides; Biomarkers; Body Weight; Chromogranin A; Colitis; Cyclohexanones; Disease Models, Animal; Endocrine Cells; Gene Expression; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; NF-kappa B; Piperidones; Rats; Serotonin; Transcription Factor AP-1; Trinitrobenzenesulfonic Acid | 2016 |
Curative ex vivo liver-directed gene therapy in a pig model of hereditary tyrosinemia type 1.
Topics: Animals; Cyclohexanones; Disease Models, Animal; Genetic Therapy; Hepatocytes; Hydrolases; Immunohistochemistry; Liver; Nitrobenzoates; Swine; Transplantation, Homologous; Tyrosinemias | 2016 |
Reprogramming metabolic pathways in vivo with CRISPR/Cas9 genome editing to treat hereditary tyrosinaemia.
Topics: Animals; Cell Line; Cell Proliferation; CRISPR-Cas Systems; Cyclohexanones; Disease Models, Animal; Enzyme Inhibitors; Exons; Gene Editing; Genetic Therapy; Hepatocytes; Humans; Hydrolases; Liver; Metabolic Networks and Pathways; Mice; Mice, Inbred Strains; Mice, Knockout; Nitrobenzoates; Oxidoreductases; Phenotype; Tyrosinemias | 2016 |
Inhibition of nuclear factor-κB signaling suppresses Spint1-deletion-induced tumor susceptibility in the ApcMin/+ model.
Topics: Adenomatous Polyposis Coli; Animals; Benzamides; Cell Transformation, Neoplastic; Cyclohexanones; Disease Models, Animal; Gene Expression Regulation, Neoplastic; Humans; Intestinal Mucosa; Membrane Glycoproteins; Mice, Knockout; Mice, Transgenic; Neoplasms; NF-kappa B; Proteinase Inhibitory Proteins, Secretory; Signal Transduction | 2016 |
Antidepressant effects of TBE-31 and MCE-1, the novel Nrf2 activators, in an inflammation model of depression.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Cyclohexanones; Depression; Disease Models, Animal; Inflammation; Male; Nerve Growth Factor; Neuronal Outgrowth; NF-E2-Related Factor 2; PC12 Cells; Phenanthrenes; Rats; Tumor Necrosis Factor-alpha | 2016 |
Loss of p21 permits carcinogenesis from chronically damaged liver and kidney epithelial cells despite unchecked apoptosis.
Topics: Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Cyclohexanones; Disease Models, Animal; Enzyme Inhibitors; Hepatectomy; Hepatocytes; Hydrolases; Kidney Diseases, Cystic; Kidney Neoplasms; Kidney Tubules, Proximal; Liver Neoplasms; Liver Regeneration; Mice; Mice, Knockout; Neoplasms; Nitrobenzoates; Tyrosinemias | 2008 |
The novel NF-kappaB inhibitor, dehydroxymethylepoxyquinomicin, prevents local and remote organ injury following intestinal ischemia/reperfusion in rats.
Topics: Animals; Anti-Inflammatory Agents; Benzamides; Cyclohexanones; Disease Models, Animal; Intestinal Diseases; Lung Diseases; Male; NF-kappa B; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2008 |
Amelioration of experimental autoimmune uveoretinitis with nuclear factor-{kappa}B Inhibitor dehydroxy methyl epoxyquinomicin in mice.
Topics: Animals; Antigen-Presenting Cells; Autoimmune Diseases; Benzamides; Cell Nucleus; Cyclohexanones; Cytokines; Disease Models, Animal; Down-Regulation; Female; Fluorescent Antibody Technique, Indirect; Injections, Intraperitoneal; Lymphocyte Activation; Mice; Microscopy, Confocal; Retina; Retinitis; T-Lymphocytes; Transcription Factor RelA; Uveitis | 2010 |
Potent cytotoxic effect of a novel nuclear factor-kappaB inhibitor dehydroxymethylepoxyquinomicin on human bladder cancer cells producing various cytokines.
Topics: Animals; Benzamides; Cyclohexanones; Cytokines; Disease Models, Animal; Drug Screening Assays, Antitumor; Humans; Mice; Mice, Nude; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 2010 |
High volume naked DNA tail-vein injection restores liver function in Fah-knock out mice.
Topics: Animals; Bilirubin; Biomarkers; Cell Proliferation; Cyclohexanones; Dependovirus; Disease Models, Animal; Genetic Therapy; Genetic Vectors; Hepatocytes; Hydrolases; Injections, Intravenous; L-Lactate Dehydrogenase; Liver; Liver Function Tests; Mice; Mice, Inbred BALB C; Mice, Knockout; Nitrobenzoates; Plasmids; Serum Albumin; Tail; Time Factors; Transfection; Tyrosinemias; Urea | 2010 |
Topical application of dehydroxymethylepoxyquinomicin improves allergic inflammation via NF-kappaB inhibition.
Topics: Active Transport, Cell Nucleus; Administration, Topical; Animals; Benzamides; Cell Line; Cyclohexanones; Dermatitis, Atopic; Disease Models, Animal; Humans; Mice; NF-kappa B | 2010 |
Hydrogen and N-acetyl-L-cysteine rescue oxidative stress-induced angiogenesis in a mouse corneal alkali-burn model.
Topics: Acetylcysteine; Animals; Antioxidants; Benzamides; Blindness; Burns, Chemical; Chemokine CCL2; Corneal Neovascularization; Cyclohexanones; Deuterium Oxide; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Eye Burns; Male; Mice; Mice, Inbred ICR; Mice, Knockout; Microscopy, Fluorescence; NF-kappa B; Oxidative Stress; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; Sodium Hydroxide; Superoxide Dismutase; Superoxide Dismutase-1; Vascular Endothelial Growth Factor A | 2011 |
N-acetyl cysteine restores brain glutathione loss in combined 2-cyclohexene-1-one and d-amphetamine-treated rats: relevance to schizophrenia and bipolar disorder.
Topics: Acetylcysteine; Animals; Bipolar Disorder; Brain; Corpus Striatum; Cyclohexanones; Dextroamphetamine; Disease Models, Animal; Frontal Lobe; Glutathione; Male; Rats; Rats, Sprague-Dawley; Schizophrenia | 2011 |
Generation of healthy mice from gene-corrected disease-specific induced pluripotent stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Chromosomes; Cyclohexanones; Disease Models, Animal; Female; Fetus; Fibroblasts; Genetic Complementation Test; Genetic Therapy; Genetic Vectors; Humans; Hydrolases; Induced Pluripotent Stem Cells; Lentivirus; Liver; Mice; Mice, Knockout; Nitrobenzoates; Pregnancy; Promoter Regions, Genetic; Spleen Focus-Forming Viruses; Tetraploidy; Tyrosinemias | 2011 |
A novel compound C12 inhibits inflammatory cytokine production and protects from inflammatory injury in vivo.
Topics: Acute Disease; Animals; Benzylidene Compounds; Cyclohexanones; Cytokines; Disease Models, Animal; Edema; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation; Inflammation; Inflammation Mediators; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Liver; Lung; Macrophages, Peritoneal; Male; Mice; NF-kappa B; Nitric Oxide; Phosphorylation; RNA, Messenger; Survival Analysis | 2011 |
Antinociceptive activity of a synthetic curcuminoid analogue, 2,6-bis-(4-hydroxy-3-methoxybenzylidene)cyclohexanone, on nociception-induced models in mice.
Topics: Analgesics; Animals; Curcumin; Cyclohexanones; Disease Models, Animal; Dose-Response Relationship, Drug; Inflammation; Inflammation Mediators; Inhibitory Concentration 50; Injections, Intraperitoneal; Male; Mice; Mice, Inbred BALB C; Naloxone; Narcotic Antagonists; Pain; Toxicity Tests, Acute | 2012 |
Nitisinone improves eye and skin pigmentation defects in a mouse model of oculocutaneous albinism.
Topics: Albinism, Oculocutaneous; Animals; Cyclohexanones; Disease Models, Animal; Enzyme Inhibitors; Enzyme Stability; Eye Color; Female; Humans; Melanins; Melanocytes; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Microscopy, Electron, Transmission; Models, Molecular; Monophenol Monooxygenase; Mutation; Nitrobenzoates; Pregnancy; Skin Pigmentation; Tyrosine | 2011 |
Cyclohexane 1,3-diones and their inhibition of mutant SOD1-dependent protein aggregation and toxicity in PC12 cells.
Topics: Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Animals; Blood-Brain Barrier; Cyclohexanones; Cyclopropanes; Disease Models, Animal; Humans; Mice; Mice, Transgenic; Mutation; Neurons; PC12 Cells; Phenyl Ethers; Rats; Superoxide Dismutase; Superoxide Dismutase-1 | 2012 |
Dehydroxymethylepoxyquinomicin (DHMEQ), a novel NF-kappaB inhibitor, inhibits allergic inflammation and airway remodelling in murine models of asthma.
Topics: Airway Remodeling; Animals; Asthma; Benzamides; Bronchoalveolar Lavage Fluid; Cells, Cultured; Cyclohexanones; Cytokines; Disease Models, Animal; Eosinophils; Epithelial Cells; Female; Humans; Inflammation; Inflammation Mediators; Leukocytes, Mononuclear; Mice; Mice, Inbred BALB C; NF-kappa B; Respiratory Hypersensitivity | 2012 |
Combined effect of dehydroxymethylepoxyquinomicin and gemcitabine in a mouse model of liver metastasis of pancreatic cancer.
Topics: Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Blotting, Western; Cell Movement; Cell Proliferation; Cyclohexanones; Deoxycytidine; Disease Models, Animal; Fluorescent Antibody Technique; Gemcitabine; Humans; Immunoenzyme Techniques; Interleukin-8; Liver Neoplasms; Matrix Metalloproteinase 9; Mice; Mice, Nude; NF-kappa B; Pancreatic Neoplasms; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured | 2013 |
Mitigation of pennyroyal oil hepatotoxicity in the mouse.
Topics: Animals; Case-Control Studies; Cimetidine; Cyclohexane Monoterpenes; Cyclohexanones; Disease Models, Animal; Disulfiram; Enzyme Inhibitors; Female; Hedeoma; Liver Diseases; Mentha pulegium; Mice; Mice, Inbred BALB C; Monoterpenes; Oils, Volatile | 2003 |
Renal proximal tubular cells acquire resistance to cell death stimuli in mice with hereditary tyrosinemia type 1.
Topics: Animals; Caspase 3; Caspase 9; Caspases; Cyclohexanones; Disease Models, Animal; DNA Fragmentation; Enzyme Inhibitors; Hepatocytes; Homogentisic Acid; Hydrolases; In Situ Nick-End Labeling; Kidney Tubules, Proximal; Mice; Mice, Knockout; Nitrobenzoates; Survival Rate; Tyrosine; Tyrosinemias | 2004 |
A novel NF-kappaB inhibitor DHMEQ selectively targets constitutive NF-kappaB activity and induces apoptosis of multiple myeloma cells in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-X Protein; Benzamides; Calcium-Binding Proteins; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspase 3; Caspase 8; Caspase 9; Caspases; Cell Line, Tumor; Cyclin D; Cyclin D1; Cyclins; Cyclohexanones; Disease Models, Animal; Down-Regulation; Enzyme Activation; Humans; Intracellular Signaling Peptides and Proteins; Membrane Glycoproteins; Mice; Mice, Inbred NOD; Mice, SCID; Multiple Myeloma; Nerve Tissue Proteins; NF-kappa B; Proto-Oncogene Proteins c-bcl-2; Synaptotagmin I; Synaptotagmins; Translocation, Genetic; Vascular Endothelial Growth Factor A | 2005 |
In vivo antitumor activity of the NF-kappaB inhibitor dehydroxymethylepoxyquinomicin in a mouse model of adult T-cell leukemia.
Topics: Animals; Antineoplastic Agents; Apoptosis; Base Sequence; Benzamides; Binding Sites; Cell Division; Cell Line, Tumor; Consensus Sequence; Cyclohexanones; Disease Models, Animal; Human T-lymphotropic virus 1; Humans; Leukemia-Lymphoma, Adult T-Cell; Mice; NF-kappa B; Transplantation, Heterologous | 2005 |
Prevention of cancer cachexia by a novel nuclear factor {kappa}B inhibitor in prostate cancer.
Topics: Albumins; Animals; Antineoplastic Agents; Benzamides; Body Mass Index; Body Weight; Cachexia; Cell Line, Tumor; Cyclohexanones; Disease Models, Animal; Dose-Response Relationship, Drug; Hematocrit; Humans; Interleukin-6; Male; Mice; Mice, Inbred BALB C; Muscle, Skeletal; Neoplasm Transplantation; NF-kappa B; Prostatic Neoplasms; Time Factors; Triglycerides; Weight Loss | 2005 |
Effect of a small molecule inhibitor of nuclear factor-kappaB nuclear translocation in a murine model of arthritis and cultured human synovial cells.
Topics: Animals; Arthritis, Experimental; Benzamides; Cell Nucleus; Cell Proliferation; Cells, Cultured; Cyclohexanones; Disease Models, Animal; Hindlimb; Humans; Injections, Subcutaneous; Male; Mice; Mice, Inbred DBA; NF-kappa B; RNA, Messenger; Synovial Membrane; Translocation, Genetic | 2005 |
Rescue from neonatal death in the murine model of hereditary tyrosinemia by glutathione monoethylester and vitamin C treatment.
Topics: Animals; Animals, Newborn; Antioxidants; Ascorbic Acid; Carcinoma, Hepatocellular; Cyclohexanones; Disease Models, Animal; Drug Therapy, Combination; Female; Glutathione; Hydrolases; Liver Neoplasms; Mice; Mice, Knockout; Nitrobenzoates; Oxidative Stress; Pregnancy; Tyrosinemias | 2008 |
Hepatic stress in hereditary tyrosinemia type 1 (HT1) activates the AKT survival pathway in the fah-/- knockout mice model.
Topics: Animals; bcl-X Protein; Carcinoma, Hepatocellular; Cyclohexanones; Disease Models, Animal; Hydrolases; Liver Neoplasms; Mice; Mice, Knockout; Nitrobenzoates; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Tyrosinemias | 2008 |
Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I.
Topics: alpha-Fetoproteins; Amino Acid Metabolism, Inborn Errors; Amino Acids; Animals; Cyclohexanones; Disease Models, Animal; Enzyme Inhibitors; Female; Heptanoates; Humans; Hydrolases; Liver; Liver Diseases; Liver Neoplasms; Male; Mice; Mice, Inbred C57BL; Nitrobenzoates; Pancreas; RNA, Messenger; Tyrosine | 1995 |
Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I.
Topics: Amino Acid Metabolism, Inborn Errors; Animals; Cell Count; Cell Transplantation; Cyclohexanones; Disease Models, Animal; Enzyme Inhibitors; Genetic Therapy; Humans; Hydrolases; Immunoenzyme Techniques; Liver; Liver Function Tests; Liver Neoplasms; Male; Mice; Mice, Inbred C57BL; Nitrobenzoates; Retroviridae; Tyrosine | 1996 |
Ex vivo hepatic gene therapy of a mouse model of Hereditary Tyrosinemia Type I.
Topics: Amino Acid Metabolism, Inborn Errors; Animals; Base Sequence; Cell Survival; Cell Transplantation; Cells, Cultured; Cyclohexanones; Disease Models, Animal; DNA, Complementary; Enzyme Inhibitors; Female; Genetic Diseases, Inborn; Genetic Therapy; Humans; Hydrolases; Liver; Male; Mice; Molecular Sequence Data; Nitrobenzoates; Tyrosine | 1998 |
A novel therapeutic trial of homogentisic aciduria in a murine model of alkaptonuria.
Topics: 4-Hydroxyphenylpyruvate Dioxygenase; Alkaptonuria; Animals; Cyclohexanones; Disease Models, Animal; Enzyme Inhibitors; Homogentisic Acid; Mice; Mice, Mutant Strains; Nitrobenzoates | 1999 |
Long-term therapy with NTBC and tyrosine-restricted diet in a murine model of hereditary tyrosinemia type I.
Topics: Animals; Cyclohexanones; Diet; Disease Models, Animal; Enzyme Inhibitors; Hydrolases; Mice; Mice, Knockout; Nitrobenzoates; Phenylalanine; Tyrosine; Tyrosinemias | 2002 |